GlassScriptPhysician profile
Keith Kowal
NPI 1528064201
$7,428.97
in general payments reported to CMS, 2019-2025
18 companies · $1,204 in 2025
The $1,204 reported for 2025 was more than what 85% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $763 · 2021: $1,075 · 2022: $1,303 · 2023: $1,256 · 2024: $1,571 · 2025: $1,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,031.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $4,988.79 | 2019-2025 | Inspire |
| Aerin Medical INC. | $656.85 | 2019-2025 | |
| Medtronic, INC. | $477.60 | 2023-2025 | Propel, Stealthstation S8 Platform, Nim-Response |
| Intersect Ent, INC. | $349.76 | 2019-2021 | |
| Optinose US, INC. | $213.69 | 2019-2024 | |
| Stryker Corporation | $186.04 | 2019-2022 | |
| Kaleo, INC. | $103.60 | 2021-2022 | |
| Genzyme Corporation | $91.24 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $76.65 | 2021-2024 | Dupixent |
| Glaxosmithkline, LLC. | $62.55 | 2021-2022 | |
| Acclarent, INC | $60.88 | 2021 | |
| Novo Nordisk INC | $43.93 | 2020 | |
| Jazz Pharmaceuticals INC. | $29.17 | 2022 | |
| Hikma Pharmaceuticals USA | $26.54 | 2023 | Ryaltris |
| Neurent Medical Limited | $16.70 | 2023 | Neuromark Device, Neuromark Radiofrequency Console |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $15.93 | 2021 | |
| Olympus America INC. | $14.82 | 2019 | |
| Medtronic USA, INC. | $14.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Kowal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.